Solar Foods Oyj Class K

Solar Foods Oyj Class K

4.71
EUR
-0.04
(-0.84%)
140.50MMarket Cap
Mar 04Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.01
- -
Basic EPS, GAAP
-0.08
-0.22
-0.37
-0.46
-0.47
- -
Free Cash Flow per Basic Share
- -
-0.73
-0.49
-0.47
-0.34
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
0.57
0.37
1.02
0.93
0.47
0.98
Tangible Book Value per Share
0.41
0.14
0.64
0.61
0.19
0.78
Basic Weighted Avg Shares
25
25
25
24
25
27
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
-136,231.26
-47,636.81
-8,414.86
- -
Depreciation Expense
1
1
7
9
9
- -
Net Income, GAAP
-2
-5
-9
-11
-12
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-180,307.67
-58,863.76
-9,318.83
- -
Working Capital
20
10
14
17
9
30
LT Debt
15
25
19
17
14
13
Total Equity
14
9
25
23
12
29
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-46.8
-52.72
-45.86
-66.87
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
3
3
3
LT Borrowings
15
14
13
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
25
30
Market Capitalization
133
116
140

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
19
15
35
Cash, Cash Equivalents & STI
13
8
27
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
6
5
Payables & Accruals
- -
- -
- -
ST Debt
3
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-49.83%
Free Cash Flow
- -
- -
-27.02%
Net Income, GAAP
- -
- -
4.5%
Sales/Revenue/Turnover
- -
- -
560.09%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
-0.21
-0.46
2025
- -
-0.25
-0.47
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Rami Jokela
Sector
Health technology
Industry
Pharmaceuticals: other
Address
Lappeenranta Finland
IPO Date
Sep 10, 2024
Business
Solar Foods Oyj is a Finland-based food biotechnology company that specializes in the research, development, and commercial production of novel single-cell proteins through gas fermentation technology. The company manufactures sustainable food-grade proteins utilizing carbon dioxide, hydrogen, electricity, and mineral nutrients, decoupling nutrition production from traditional agriculture, arable land use, and climatic conditions. Its flagship product is Solein, a versatile, single-cell microbial protein ingredient comprising essential amino acids, iron, dietary fiber, and B-vitamins. The company's product and service portfolio comprises Solein bulk protein powder for industrial food manufacturing; specialized nutritional formulations for the health, active lifestyle, and performance nutrition segments, including ready-to-mix powders and ready-to-drink beverages; functional food matrices for dairy, egg, and meat alternatives, such as non-dairy beverages, yogurts, spreads, and mayonnaise; fortified dry ingredients for baked goods, pasta, snacks, and confectionery; and proprietary concept development, prototype formulation, and bioprocess application support services for commercial food brand partners. Founded in 2017 and headquartered in Vantaa, Finland, Solar Foods serves food manufacturers and consumer packaged goods enterprises across international markets, including Singapore, the United States, Japan, and the European Union. In recent developments, the company completed its public listing on the Nasdaq First North Growth Market Finland in September 2024 under the ticker symbol SFOODS. Solar Foods has achieved full operational scale-up at its commercial-scale demonstration facility, Factory 01, in Vantaa and secured 77.8 million euros in grant and loan financing to fund the planning and construction of Factory 02, an industrial-scale manufacturing plant located in Lappeenranta, Finland. The company has also expanded its global commercial footprint through product development partnerships with Ajinomoto, Ambrosia Collective, and Fermenta, secured energy infrastructure agreements with Fortum, obtained United States patent clearance for its production methodology, and advanced regulatory expansion through a U.S. Generally Recognized as Safe notification alongside European Union novel food approval filings.